Patient's voice Rheumatoid Arthritis & Psoriasis

Patient organizations

The clinical trial, named EPIPSORA is an observational study to develop and validate an epigenetic biomarker panel that can predict treatment success in RA and PsO patients.

The EPIPSORA Observational Study will start in 2023 in various European hospitals in The Netherlands, Belgium and Portugal, and will take 3 years to complete. 200 patients will participate in the trial.

The below patient organizations are active in the 3 countries where the EPIPSORA trial will be carried out.